MDxHealth Correlations
MDXH Stock | USD 1.96 0.02 1.03% |
The current 90-days correlation between MDxHealth SA ADR and Inozyme Pharma is 0.16 (i.e., Average diversification). The correlation of MDxHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
MDxHealth Correlation With Market
Average diversification
The correlation between MDxHealth SA ADR and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MDxHealth SA ADR and DJI in the same portfolio, assuming nothing else is changed.
MDxHealth |
Moving together with MDxHealth Stock
0.61 | ELAN | Elanco Animal Health Potential Growth | PairCorr |
0.61 | HLN | Haleon plc | PairCorr |
0.76 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.69 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.83 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.72 | RDY | Dr Reddys Laboratories | PairCorr |
0.79 | TAK | Takeda Pharmaceutical | PairCorr |
0.64 | LTRN | Lantern Pharma | PairCorr |
0.71 | AMGN | Amgen Inc | PairCorr |
0.61 | ANRO | Alto Neuroscience, | PairCorr |
0.85 | SIGA | SIGA Technologies | PairCorr |
Moving against MDxHealth Stock
0.83 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.82 | EWTX | Edgewise Therapeutics | PairCorr |
0.77 | BHC | Bausch Health Companies | PairCorr |
0.76 | GILD | Gilead Sciences | PairCorr |
0.71 | ESPR | Esperion Therapeutics | PairCorr |
0.65 | GANX | Gain Therapeutics | PairCorr |
0.55 | EBS | Emergent Biosolutions | PairCorr |
0.54 | WAT | Waters | PairCorr |
0.45 | VTRS | Viatris | PairCorr |
0.45 | BCTXW | BriaCell Therapeutics | PairCorr |
0.41 | HCM | HUTCHMED DRC | PairCorr |
0.4 | BFRIW | Biofrontera Warrants | PairCorr |
0.82 | BSX | Boston Scientific Corp | PairCorr |
0.48 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.4 | MNMD | Mind Medicine | PairCorr |
0.4 | ABT | Abbott Laboratories Fiscal Year End 22nd of January 2025 | PairCorr |
0.39 | DXCM | DexCom Inc | PairCorr |
0.31 | CMND | Clearmind Medicine Common | PairCorr |
Related Correlations Analysis
0.08 | 0.04 | -0.73 | 0.09 | INZY | ||
0.08 | 0.71 | 0.45 | 0.02 | DAWN | ||
0.04 | 0.71 | 0.55 | 0.23 | ABOS | ||
-0.73 | 0.45 | 0.55 | -0.03 | ELDN | ||
0.09 | 0.02 | 0.23 | -0.03 | ELEV | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MDxHealth Stock performing well and MDxHealth Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MDxHealth's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
INZY | 2.76 | (1.20) | 0.00 | (0.59) | 0.00 | 5.07 | 16.62 | |||
DAWN | 2.05 | (0.11) | 0.00 | (0.02) | 0.00 | 3.84 | 11.44 | |||
ABOS | 3.55 | (0.55) | 0.00 | (0.08) | 0.00 | 7.52 | 28.07 | |||
ELDN | 3.47 | 0.70 | 0.17 | 16.47 | 3.04 | 10.09 | 28.12 | |||
ELEV | 3.51 | (0.48) | 0.00 | (0.11) | 0.00 | 5.77 | 22.21 |
MDxHealth Corporate Management
Wim Criekinge | Chief Officer | Profile | |
Joseph Sollee | Executive Counsel | Profile | |
Ron CPA | Chief Officer | Profile | |
John Bellano | Chief Officer | Profile | |
Jason Poole | Chief Officer | Profile | |
Miriam Reyes | Executive Operations | Profile | |
Paul Marr | Ex America | Profile |